SBC Medical Group Holdings Incorporated (NASDAQ:SBC – Free Report) – Research analysts at Zacks Small Cap issued their Q3 2024 earnings estimates for SBC Medical Group in a report released on Wednesday, October 23rd. Zacks Small Cap analyst M. Marin forecasts that the company will earn $2.36 per share for the quarter. Zacks Small Cap also issued estimates for SBC Medical Group’s Q4 2024 earnings at $2.41 EPS, FY2024 earnings at $9.46 EPS and FY2025 earnings at $10.50 EPS.
SBC Medical Group Price Performance
NASDAQ SBC opened at $7.15 on Friday. SBC Medical Group has a twelve month low of $5.30 and a twelve month high of $36.52.
About SBC Medical Group
SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand.
Featured Stories
- Five stocks we like better than SBC Medical Group
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- The How and Why of Investing in Gold Stocks
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- Consumer Staples Stocks, Explained
- MarketBeat Week in Review – 10/21- 10/25
Receive News & Ratings for SBC Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SBC Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.
